Research
Researchers at Yale School of Medicine said they’ve solved a longstanding mystery of how mutations in the C9ORF72 gene, a common genetic cause of amyotrophic lateral sclerosis (ALS), may lead to toxic proteins. The findings…
A wearable robot that detects small arm motions and helps support the shoulder can make it easier for amyotrophic lateral sclerosis (ALS) patients to pick up and carry things, a study showed.…
The ALS Network is driven by passion — for people, for progress, and for a future without ALS. We partner with world-class researchers, clinicians, and institutions across California and Hawaii…
In the beginning, not even Hynek Wichterle’s postdoc thought his idea to slow the progression of ALS had a chance. “When Hynek proposed this, I thought it would never work…
Letter To: Richard Hodes, MD, Director of the National Institute on Aging Walter Koroshetz, MD, Director of the National Institute of Neurological Disorders and Stroke National Institutes of Health, 9000…
ALS Network Partners with Barrow Neurological Institute to Engage Next Generation of ALS Researchers
The ALS Network and the Barrow Neurological Institute have teamed up to provide hands-on experience to promising young researchers. Ria Moharil, an incoming second-year neuroscience student at Arizona State University,…
The ALS Network presented four researchers with the Barber Research Award during the UC ALS Reinvigorating Innovation in ALS Research workshop on May 15-16. From left to right: Julie Smeyers,…
Left to Right: Sheri Strahl, MPH, MBA, President and CEO, ALS Network; Christopher J. McDermott, MBChB, FRCP, PhD, University of Sheffield; Neil A. Shneider, MD, PhD, Columbia University; Jim Essey,…
A groundbreaking experimental therapy for a rare, aggressive form of ALS caused by FUS gene mutations has produced surprising clinical improvements in some patients, including restored mobility and extended survival.…
MaaT033, an oral therapy aiming to restore balance to the collection of bacteria and other microbes in the gut, was safe and well tolerated after three months and showed signs…